Featured Articles
-
Optimizing mRNA For Success: A Guide To Enhanced Stability, Delivery, And Efficacy
6/11/2024
RNA offers exciting potential for vaccines, gene therapies, and personalized medicine, but challenges related to stability, delivery, and manufacturing persist.
-
The Next Generation Of mRNA Products: Implications For Quality Control
5/30/2024
To fully realize the potential of mRNA as a therapeutic or vaccine modality, developers will need to employ cutting-edge analytical methods to ensure the safety and efficacy of these novel products.
-
Benefits Of PCR-Based mRNA Manufacturing Processes
5/17/2024
Learn about a proprietary polymerase chain reaction (PCR) solution that was developed to overcome the challenges associated with pDNA that applies the high accuracy of PCR to mRNA manufacturing.
-
De-Risk mRNA Regulatory Approvals
4/29/2024
Gain insight into how you can de-risk mRNA regulatory approvals with critical quality attribute characterization and lot release testing.
-
Formulation Process And Analytical Development Capabilities
3/25/2024
Explore process and analytical development capabilities that can help you advance your formulation to GMP Manufacturing.
-
Advancing A LNP Formulation To Clinical And Commercial Manufacturing
3/25/2024
Lipid selection impacts the final LNP drug product and the LNP process. Review critical quality considerations for lipids and the process requirements for successful commercial-scale manufacturing.
-
Contrast In Oligonucleotides
3/13/2024
Explore the differences between research-use-only oligonucleotides and those manufactured in compliance with GMP 21 CFR 820.
-
Vaccine Maker's Toolkit: Strategies For Manufacturing And Supply Management
11/7/2023
This collection of insights highlights strategies and guidance to ensure reliable biomanufacturing capacity and supply chains for the delivery of health technologies, even during crisis conditions.
-
Streamlining Biomanufacturing Automation With Connectivity And Integration
10/29/2023
Gain insight into the recent advancements in connectivity and integration technology, the associated challenges, and the importance of a vendor-neutral approach.
-
Economics For Vaccine Manufacturing: Comparing Traditional To Modern Modalities
9/11/2023
Explore key points from the presentation MilliporeSigma delivered on the analysis and comparison of manufacturing costs between traditional and modern vaccines at the World Vaccine Congress Washington 2023.